Your Notifications
All done, no notifications

What is Chronic Lymphocytic Leukemia (CLL)?

Chronic lymphocytic leukemia (CLL) is a type of blood cancer in which abnormal lymphocytes, most commonly B lymphocytes, accumulate in the blood, bone marrow, lymph nodes, and spleen. CLL usually develops slowly and may not cause symptoms early on.

The disease can affect the normal production and function of blood cells, potentially leading to anemia, increased susceptibility to infections, or low platelet counts. CLL is closely related to small lymphocytic lymphoma (SLL), with the distinction primarily based on where the abnormal lymphocytes are found.

What is the Importance of Timely Treatment?

A timely diagnosis helps determine the extent and biological characteristics of CLL and whether treatment is needed. Not every person diagnosed with CLL needs immediate treatment. Patients without symptoms or with stable disease may be managed with active surveillance, including regular blood tests and clinical assessments.

What are the Common Symptoms of Chronic Lymphocytic Leukemia (CLL)?

  • Persistent fatigue or weakness
  • Painless swelling of lymph nodes in the neck, armpits, or groin
  • Frequent or recurrent infections
  • Unexplained weight loss
  • Fever without an obvious infection
  • Drenching night sweats
  • Easy bruising or bleeding
  • Shortness of breath related to anemia
  • Abdominal fullness or discomfort due to an enlarged spleen

Causes and Risk Factors of Chronic Lymphocytic Leukemia (CLL)

Causes

  • The exact cause of CLL is not known. The disease develops when genetic and molecular changes cause abnormal B lymphocytes to survive and accumulate. These abnormal cells can gradually build up in the blood, bone marrow, lymph nodes, and spleen.

Risk Factors

  • Increasing age
  • Male sex
  • Having a first-degree relative with CLL or another related lymphoid cancer
  • Certain inherited genetic susceptibility factors
  • Being of European ancestry, as CLL occurs less frequently in some other populations

Latest Research and Technologies in the Treatment of Chronic Lymphocytic Leukemia (CLL) in the United Arab Emirates

  • CLL treatment has advanced with targeted therapies and molecular risk assessment, including BTK inhibitors and the BCL2 inhibitor, which may be combined with antibodies. Genetic and molecular testing, including abnormalities and mutation status, helps guide treatment selection, while newer options such as the non-covalent BTK inhibitor and cellular therapies expand treatment options for selected patients with relapsed or refractory CLL.

Treatment options for Chronic Lymphocytic Leukemia (CLL)

Active surveillance: Patients with early or asymptomatic CLL may be monitored regularly without immediate treatment.

Combination therapy: Targeted medicines may be combined with antibodies or other agents depending on the patient's disease characteristics.

Chemotherapy : Traditional chemotherapy has a more limited role than in the past but may still be considered in specific circumstances.

CAR-T Cell Therapy : It is specifically approved as a highly effective option for adults with relapsed or refractory CLL who have already exhausted standard BTK and BCL-2 inhibitor treatments.

Cost Start From 110000Explore Options

Stem cell transplantation : Allogeneic stem cell transplantation may be considered for a small number of carefully selected patients with high-risk, treatment-resistant disease.

  • Clinical assessment:
    • Complete blood count (CBC): Identifies lymphocytosis and evaluates red blood cells and platelets.
    • Peripheral blood smear: Helps assess the morphology of circulating lymphocytes.
    • Flow cytometry: Identifies the characteristic immunophenotype of CLL cells and helps confirm the diagnosis.
    • Biochemical tests: Kidney and liver function tests and other blood investigations may be performed to assess overall health and treatment readiness.
    • Genetic and molecular tests: FISH, TP53 testing, IGHV mutation status, and other molecular investigations can provide prognostic and treatment-related information.
  • Imaging Tests:
    • CT scan: May evaluate enlarged lymph nodes, spleen, or other areas when clinically indicated.
    • PET/CT: Is not routinely required for uncomplicated CLL but can be useful when transformation to a more aggressive lymphoma is suspected.
    • Ultrasound: May be used to assess the spleen, liver, or accessible lymph nodes in selected situations.

MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive tele-rehabilitation services designed to support Chronic Lymphocytic Leukemia (CLL) patients in the United Arab Emirates. These services include:

  • Physical activity: Appropriate activity can help maintain muscle strength, mobility, and endurance.
  • Physiotherapy: May help with weakness, reduced mobility, or treatment-related physical limitations.
  • CLL medicines primarily target abnormal lymphocytes and the pathways that allow them to survive. Commonly used treatments include BTK inhibitors. Anti-CD20 monoclonal antibodies. Newer medicines, including non-covalent BTK inhibitors such as pirtobrutinib, may be considered in certain relapsed or treatment-resistant cases. Supportive medicines may also be used to manage infections, anemia, treatment-related side effects, or other complications.

Instantly Connect with our Specialists

Doctor 1
Doctor 2
Doctor 3
Doctor 4
Doctor 5
Doctor 6
Doctor 7
Doctor 8

Hospitals for Chronic Lymphocytic Leukemia (CLL) in United Arab Emirates

Kings College Hospital Dubai: Top Doctors, and Reviews
Kings College Hospital Dubai

Dubai, United Arab Emirates

Apart from in-detail treatment procedures available, Kings College Hospital Dubai located in Dubai, United Arab Emirates has a wide variety of facilities available for International Patients. Some of the facilities which are provided by them are Accommodation, Airport Transfer, Choice of Meals, Interpreter, SIM, TV inside room. Also listed below are some of the most prominent infrastructural details:

  • 100 beds in the Hospital
  • Operation Theatres
  • Special Intensive Care Units
  • 24*7 Emergency Department
  • Covid-19 Treatment Clinic
  • Wound & Stoma care center
  • Doctor on call (Telemedicine) is also available
Message Us

161

PROCEDURE

27

DOCTORS IN 12 SPECIALITIES

19+

FACILITIES & AMENITIES

Quttainah Specialized Hospital: Top Doctors, and Reviews
Quttainah Specialized Hospital

Dubai, United Arab Emirates

It is with this goal in mind that we at Quttainah Specialized Hospital provide a team of international standards and the highest level of expertise in aesthetics, plastic, and reconstructive treatment to ensure the delivery of the highest quality medical approach to appreciating and cultivating individual beauty needs. Our experts are here to handle it all.

Message Us

143

PROCEDURE

8

SPECIALITIES

10+

FACILITIES & AMENITIES

Thumbay University Hospital, Ajman: Top Doctors, and Reviews
Thumbay University Hospital, Ajman

Ajman, United Arab Emirates

Thumbay University Hospital, Ajman located in Ajman, United Arab Emirates is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

  • The hospital has a 250 bed capacity.
  • Excellent quality of healthcare facilities and services at par with developed countries.
  • Multilingual and multinational healthcare professionals working in the Thumbay Hospital Ajman (belonging to 20 nations and fluent in 50 plus languages).
  • Equipped with the newest facilities to ensure highest standards of healthcare delivery to patients at economical costs.
  • Dedicated, compassionate and highly educated healthcare professionals work in Thumbay Hospital Ajman.
  • Well developed diagnostic facilities are also available.
  • A 24/7 functioning emergency care department and advanced facilities in Radiology.
  • There is presence of an ultramodern Catheterization Lab (Cath Lab) and Electrosurgery Cryotherapy in dermatology, Interlocking intramedullary nailing.
  • Also available under dental departments Panoramic, digital intra-oral X-rays, Cephalogram are present.
  • Some of the important specialties in Thumbay Hospital Ajman are:
    • Ear, nose, and throat
    • Cardiovascular
    • Bariatric surgery
    • General surgery
    • Urology
    • Nephrology

Message Us

253

PROCEDURE

40

DOCTORS IN 14 SPECIALITIES

13+

FACILITIES & AMENITIES

Our Services to better your experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Why Choose the United Arab Emirates for Chronic Lymphocytic Leukemia (CLL) Treatment?

  • Experienced hematologists: Specialists with expertise in leukemia diagnosis, risk assessment, targeted therapy, and long-term disease management.
  • Advanced diagnostic facilities: Flow cytometry, cytogenetic testing, FISH, molecular testing, and advanced imaging can support diagnosis and treatment planning.
  • Modern targeted therapies: Eligible patients may have access to BTK inhibitors, BCL2 inhibitors, monoclonal antibodies, and newer treatment approaches.
  • Multidisciplinary care: Hematologists, oncologists, pathologists, radiologists, transplant specialists, and supportive-care teams can collaborate on complex cases.
  • International patient support: Many major hospitals provide dedicated services for international patients, including treatment coordination, documentation, accommodation, travel assistance, and follow-up planning.

Frequently Asked Questions

There is no fixed recovery period for CLL because it is often a long-term condition that may be monitored or treated over different periods. Recovery from active treatment depends on the therapy used, disease response, side effects, and the patient's overall health.

Yes. Most people with CLL can walk and remain physically active if their health permits. Activity may need to be adjusted during periods of significant fatigue, anemia, infection, low blood counts, or treatment-related side effects.

Some specialised UAE hospitals offer diagnostic services such as flow cytometry, FISH, and molecular testing to support CLL diagnosis and treatment planning. Availability of newer therapies varies by hospital, regulatory approval, and individual eligibility. Patients should confirm access to a specific medicine or treatment before arranging care.

Many major UAE hospitals have international patient departments that assist with medical appointments, treatment coordination, travel documentation, accommodation, interpretation, and follow-up arrangements.

Look for a centre with experienced hematologists, specialised leukemia services, advanced flow cytometry and molecular diagnostics, access to targeted therapies, and multidisciplinary care. For complex or relapsed CLL, consider whether the centre offers advanced treatment options and, when clinically appropriate, transplant or cellular-therapy services.

There is no single success rate for CLL. Outcomes vary by age, disease stage, genetic and molecular characteristics, overall health, prior treatments, and response to therapy. Many patients can achieve prolonged disease control with modern treatment, but CLL may require long-term monitoring.

the United Arab Emirates has specialised hematology and oncology centres with experience in diagnosing and treating leukemia, including CLL. Patients should consider the specialist's experience with CLL and the hospital's available diagnostic, treatment, transplant, and supportive-care facilities.

Risks vary by treatment. Targeted medicines can cause treatment-specific effects such as infections, bleeding, heart-rhythm problems, high blood pressure, or tumour lysis syndrome. Immunotherapy can cause infusion or immune-related reactions, while chemotherapy can cause low blood counts, infections, nausea, and fatigue. Your doctor will assess individual risks before treatment.

Consult a haematologist to discuss your diagnosis, disease status, test results, and monitoring or treatment plan. Ask whether active surveillance is appropriate or whether there are indications to begin treatment. Seek prompt medical advice for fever, signs of infection, unusual bleeding, rapidly enlarging lymph nodes, or new or worsening symptoms.

CLL does not typically cause permanent physical deformities. However, enlarged lymph nodes or an enlarged spleen may cause discomfort or other symptoms, while anemia, infections, and treatment-related effects can affect physical function. The impact varies from person to person, and appropriate disease management and supportive care can help address symptoms and complications.

Yes. Fatigue, recurrent infections, enlarged lymph nodes, treatment side effects, emotional stress, and concerns about long-term disease management can affect quality of life. Physical activity, nutritional care, symptom management, and psychological support can help address these challenges.

Some people with early or asymptomatic CLL can remain stable for years without treatment and may be safely monitored through active surveillance. However, progressive CLL can cause worsening blood counts, enlarged lymph nodes or spleen, recurrent infections, and other complications. In some patients, CLL can transform into a more aggressive lymphoma.

No established way exists to prevent CLL because its exact cause is not fully understood. Age, inherited susceptibility, and some other risk factors cannot be changed.

Yes. CLL is more common in older adults and occurs more frequently in men than women. It is also more common among people of European ancestry than in some other populations. Having a close relative with CLL or a related lymphoid cancer can also increase risk.

Author

Dr. Vijita Jayan
Dr. Vijita Jayan

BPT, MPT (Neuro)

18 Years of Experience

With over 18 years of distinguished clinical experience, Dr. Vijita Jayan is a highly accomplished Clinical Director and Rehabilitation Specialist, renowned for her expertise in neuro-rehabilitation, functional recovery, and mobility-dependent case management. Her extensive practical knowledge enables her to design and implement individualized, evidence-based rehabilitation protocols that consistently yield measurable patient outcomes. A prolific researcher and academic writer, she has authored numerous peer-reviewed articles and research papers, significantly advancing the field of rehabilitative medicine. The recipient of multiple prestigious accolades, Dr. Jayan is widely regarded as one of the foremost authorities in Physical Medicine and Rehabilitation, continually shaping neuro-rehabilitative care through research, innovation, and clinical excellence. View More

Reviewer

Dr. Mohit Agarwal
Dr. Mohit Agarwal

Medical Oncologist

14 Years of Experience

One of the finest Oncologist in New Delhi, India, Dr. Mohit Agarwal has worked with several world class multidisciplinary hospitals over the years. Dr. Mohit Agarwal has over 14+ years of experience in his field. The doctor treats and manages a wide range of conditions such as Stomach Cancer, Rectal Cancer, Breast Cancer, Brain Cancer View More

Last Reviewed - January 2026